Login / Signup

Towards improved diagnosis: radiomics and quantitative biomarkers in 18 F-PSMA-1007 and 18 F-fluorocholine PET/CT for prostate cancer recurrence.

Emmanouil PanagiotidisSotiria AndreouAnna PaschaliKyra AngeioplastiEvaggelia VlontzouTheodore KalathasAngeliki PipintakouAthina FothiadakiAnna MakridouMichael ChatzimarkouEmmanouil PapanastasiouIoannis DatserisVasiliki Chatzipavlidou
Published in: Nuclear medicine communications (2024)
Our analysis using both radiomic features and quantitative biomarkers demonstrated the improved performance of 18 F-PSMA-1007 compared with FCH in identifying metastatic lesions in prostate cancer patients with BCR.
Keyphrases